Recent 13F filings as of September 2025 show that 282 institutional investors hold a position in Krystal Biotech, Inc. (NASDAQ:KRYS).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 30 Sep, 2025 | 4,341,447 | 6,686 | 0.15% | $766,395,653.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 3,834,128 | -11,027 | -0.29% | $676,838,615.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 2,792,208 | -30,680 | -1.09% | $492,908,477.00 |
| Avoro Capital Advisors LLC | 30 Sep, 2025 | 2,777,777 | 117,777 | 4.43% | $490,360,974.00 |
| STATE STREET CORP | 30 Sep, 2025 | 1,395,967 | 40,621 | 3.00% | $246,430,055.00 |
| Soleus Capital Management, L.P. | 30 Sep, 2025 | 1,018,831 | 95,873 | 10.39% | $179,854,236.00 |
| Capital World Investors | 30 Sep, 2025 | 809,240 | -133,009 | -14.12% | $142,855,137.00 |
| Frazier Life Sciences Management, L.P. | 30 Sep, 2025 | 688,460 | 0 | 0.00% | $121,533,844.00 |
| Redmile Group, LLC | 30 Sep, 2025 | 661,388 | -2,083 | -0.31% | $116,754,824.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 636,988 | 636,892 | 663,429.17% | $112,447,492.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 611,244 | -8,303 | -1.34% | $107,918,493.00 |
| Hood River Capital Management LLC | 30 Sep, 2025 | 606,946 | 73,923 | 13.87% | $107,144,177.00 |
| DIMENSIONAL FUND ADVISORS LP | 30 Sep, 2025 | 533,964 | 28,075 | 5.55% | $94,260,975.00 |
| BRAIDWELL LP | 30 Sep, 2025 | 520,401 | -207,410 | -28.50% | $91,866,389.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 30 Sep, 2025 | 467,058 | 205,675 | 78.69% | $82,451.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 348,250 | -182,111 | -34.34% | $61,476,572.00 |
| FIRST TRUST ADVISORS LP | 30 Sep, 2025 | 248,392 | 26,022 | 11.70% | $43,848,639.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 248,165 | -3,243 | -1.29% | $43,808,568.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 30 Sep, 2025 | 242,863 | -3,317 | -1.35% | $42,872,605.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 234,578 | 157 | 0.07% | $41,410,202.00 |